Evidence map›Paper›PMID 40283633›Full record

ArticleJournal of clinical medicine2025

Diagnostic Yield of CE-EBUS in Mediastinal and Hilar Lymphadenopathy: A Preliminary Study.

Ilaria Suriano, Luca Frasca, Filippo Longo, Antonio Sarubbi, Giovanni Tacchi, Pierfilippo Crucitti

Registry-linked trialAbstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07060378 (A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07060378 narecruitingnot on this map

A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes

TypeinterventionalSponsorShanghai Chest HospitalRan2025 to 2026Enrolled250ConditionsLung Lesions, Mediastinal and Hilar Lymph Node EnlargementArmsContrast-enhanced endobronchial ultrasound
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ilaria SurianoDepartment of Thoracic Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy.ORCID 0009-0000-5648-011X
Luca FrascaDepartment of Thoracic Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy.ORCID 0000-0001-7188-5107
Filippo LongoDepartment of Thoracic Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
Antonio SarubbiDepartment of Thoracic Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy.ORCID 0009-0002-1048-6625
Giovanni TacchiDepartment of Thoracic Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy.ORCID 0000-0002-7378-0111
Pierfilippo CrucittiDepartment of Thoracic Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy.ORCID 0000-0003-1509-6714

Funding

Un Respiro per la Vita E.T.S. Lung Cancer research funding
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CE-EBUSEBUSlung cancermediastinal stagingsulfur hexafluoride

Identifiers

PMID40283633
PMCPMC12027627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.